Medication screen links a few drugs to lower mortality in adults
An analysis of 8.93 million adults aged 40 or older in six cohorts found that most prescription medications were linked to higher mortality.
Our read
AI & data- Studied:
- Preprint: cohort study of adults in All of Us, against matched unvaccinated individuals (Multicenter)
- What changed:
- Death from any cause was lower among shingles vaccine recipients than matched unvaccinated individuals (HR 0.61)
- The catch:
- Selection of healthier medication users contributed to the lower mortality associations
- In the record:
- The 170th paper on estradiol with results in people; 707 on record in all.
Editor of record: Boris Djordjevic · AgingResearch.News
Adults aged 40 or older in the UK, US, Finland, Hong Kong and Japan were included in an observational analysis covering 1.49 billion prescriptions. Most medications were associated with higher mortality, reflecting the illnesses for which people received them.
A few medications were linked to lower mortality: a vaccine against varicella-zoster, the virus that causes shingles; the antimalarial drugs atovaquone-proguanil and mefloquine; and estradiol hormone therapy. Adjusting for existing illnesses, lifestyle and socioeconomic factors only modestly weakened these associations. Accounting for self-reported health erased the atovaquone-proguanil association, probably reflecting healthier travelers, but the vaccine association remained. The authors concluded that selection of healthier people contributed to these signals but did not appear to fully explain the vaccine association. They called for randomized trials to confirm it.
Why it matters
The authors propose that comparing medications’ links with mortality across health systems can help prioritize existing drugs for testing in aging research.
Caveats
People who received these medications may have differed in health from those who did not, beyond the differences the analyses accounted for. The findings are from a preprint that has not been peer-reviewed.
- Atovaquone + proguanil
- Mefloquine
- Estradiol
- Varicella zoster virus vaccine
- Resources: datasets, atlases and tools
- Humans
The paper
Institute of Oncology Research (IOR), Bellinzona, Switzerland
medRxiv, Nov 13, 2026, Open access, CC BY, Preprint, not yet peer-reviewed
Comments
Be the first to comment.